Loading…

Transcultural adaptation of the EULAR activity index for primary Sjogren's syndrome in Argentine

To adapt the EULAR Activity Index for primary Sjögren's syndrome (ESSDAI) to the Argentine population. observational, cross-sectional study that included patients in a period of ten months. Three Argentine rheumatologists adapted and translated to Spanish the original version in English and the...

Full description

Saved in:
Bibliographic Details
Published in:European journal of rheumatology 2020-01, Vol.7 (1), p.16-20
Main Authors: Secco, Anastasia, Marino, Lucila, Herscovich, Natalia, Aicardi, Pedro, Techera, Lorena, Takashima, Lorena, Santiago, María Lida, Romanini, Felix, Mamani, Marta, Catalán Pellet, Antonio C
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To adapt the EULAR Activity Index for primary Sjögren's syndrome (ESSDAI) to the Argentine population. observational, cross-sectional study that included patients in a period of ten months. Three Argentine rheumatologists adapted and translated to Spanish the original version in English and the final version was translated back into English by a research associate whose mother language was English. In order to estimate the constructive validity of the index, the visual analogous scale (VAS) of disease activity was used by experts. A subgroup of patients attended a second visit in order to evaluate test-retest reliability. 51 patients were included, 49 (96.1%) were female, the median age was 58 ((interquartile range (IQR): 49-69)). The median global VAS was 10 (IQR: 4-22.25) and the median total ESSDAI score was 5 (IQR: 3-9). The correlation between the global VAS and the total ESSDAI score of the scale was 0.79. The intraclass correlation coefficient was 0.67 (95% CI: 0.32-0.92) for the total score and 0.98 (95% CI: 0.92-0.995) for the global VAS. The results of the correlation coefficient between the VAS and the scale for each domain were: constitutional symptoms: 0.46; lymphadenopathy: 0.76; glandular: 0.78; joint: 0.61; skin: 1; respiratory: 0.83; renal: 1; muscular:- (no patient had myositis); peripheral nervous system: 0.72; central nervous system: 0.67; hematological: 0.96; biomarkers: 0.86. The results of this study showed that the ESSDAI is a reliable and valid index for this pSS argentinian population.
ISSN:2147-9720
2148-4279
DOI:10.5152/eurjrheum.2019.19143